FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to therapeutic ophthalmology, and can be applied for therapy of acute thrombosis of retina veins. For this purpose per-orally prescribed is "Thrombovasim" in dose 2 pills (200 U) 2 times per day 30 minutes before meal during 20-25 days and parabulbarly sodium etamsylate (dicinone) 12.5% 0.5 ml No 5, dexamethasone 0.4% 0.5 ml with heparin 750-1000 U; intramuscularly sodium etamsylate 12.5% 2 ml 2 times per day 5-10 days, per-orally thrombo-ass 50-100 mg before going to bed for life, lasix 20 mg intramuscularly No 3 or inside diacarb 250 mg 1 time per 3 days.
EFFECT: method makes it possible to reduce risk of thrombosis in bloodstream in general without impact on indices of blood coagulation and bleeding and, respectively, minimise of risk of developing side effects and complications.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION ELICITING THROMBOLYTIC AND FIBRINOLYTIC EFFECT | 2002 |
|
RU2216348C1 |
| METHOD FOR TREATING HEMORRHAGES INTO INTERNAL MEDIA AND MEMBRANES OF AN EYE ACCOMPANIED WITH BLOOD PLATELETS HYPERAGGREGATION | 1998 |
|
RU2161020C2 |
| METHOD FOR TREATING PATIENTS WITH ACUTE THROMBOSIS OF VENOUS BED OF LOWER EXTREMITIES | 2016 |
|
RU2613155C1 |
| METHOD FOR TREATING HEMORRHAGE INTO EYE INTERNAL MEDIA AND SCLERA AND RETINA | 1996 |
|
RU2119316C1 |
| METHOD FOR TREATING HEMORRHAGES INTO INTERNAL MEDIA AND TUNICS OF THE EYE | 1995 |
|
RU2115396C1 |
| METHOD FOR TREATMENT AND PREVENTION OF RECURRENT VENOUS THROMBOSIS AFTER THE NOVEL CORONAVIRUS INFECTION | 2022 |
|
RU2791373C1 |
| METHOD OF TREATMENT OF CLOTTAGE OF CENTRAL VIENNA OF RETINA | 2007 |
|
RU2352304C1 |
| METHOD OF THROMBOLYTIC THERAPY | 1992 |
|
RU2141315C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH ACUTE THROMBOPHLEBITIS OF SUPERFICIAL VEINS OF LOWER EXTREMITIES | 2021 |
|
RU2759653C1 |
| METHOD FOR THROMBOLYSIS IN CIRCULATORY DISORDERS OF THE EYEBALL AND THE RETROBULBAR SPACE (VARIANTS) | 2021 |
|
RU2785494C1 |
